Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
5
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
5
×
fda
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
5
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
ipo
clinical trials
gene therapy
vc
venture capital
abbvie
allergan
astrazeneca
cancer
celgene
What
bio
roundup
ipo
biogen
covid
fda
medicines
new
years
acquisitions
activity
allogene
america
announced
approvals
august
biotech
busy
cancer
ceo
clamped
collabs
continues
convoluted
crispr
daniel
days
deal
decisions
delays
democrats
developing
devices
diversity
dreams
drugs
economic
fast
gilead
gilead’s
Language
unset
Current search:
novartis
×
biogen
×
" detroit top stories "
×
" san francisco top stories "
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More